Study to Explore the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AHT956 in Healthy Subjects
NCT00410228 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2007-06-22
Summary
This study will evaluate the safety and tolerability of ascending single oral doses of AHT956 in healthy subjects
Conditions
- Healthy
Interventions
- DRUG
-
AHT956
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis · Investigator site
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-06-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female Subjects
NCT00953888 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of ETH47 in Healthy Participants
NCT07055321 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO5545965 in Healthy Volunteers
NCT01864226 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy Subjects
NCT01815684 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants
NCT07110610 ·Status: RECRUITING ·Phase: PHASE1
-
A Placebo-controlled Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects
NCT04608513 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of AZD8566.
NCT00749333 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy Volunteers
NCT02953132 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants
NCT06612970 ·Status: RECRUITING ·Phase: PHASE1
-
AZD5985 Single Ascending Dose Study
NCT00967356 ·Status: TERMINATED ·Phase: PHASE1
-
Phase 1a Study in Healthy Participants
NCT05953506 ·Status: UNKNOWN ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 in Japanese and Chinese Healthy Volunteers..
NCT05955183 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-389949 in Healthy Subjects
NCT02099201 ·Status: COMPLETED ·Phase: PHASE1
-
Study Of Single Dose Of ATN-103 Administered To Healthy Japanese Male Subjects
NCT00916110 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Safety, Tolerability, and Pharmacokinetics of INE963 in Healthy Participants
NCT04896632 ·Status: TERMINATED ·Phase: PHASE1
-
Single and Multiple Ascending Oral Dose Study of RX-10001 in Healthy Volunteers
NCT00941018 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Ascending Doses of AZD5069 in Healthy Volunteers
NCT01051505 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-Human Study of Single and Multiple Doses of anle138b in Healthy Subjects
NCT04208152 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of AG-348 in Healthy Volunteers
NCT02108106 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Subjects to Assess the Safety, Tolerability and Pharmacokinetics of HTL0022562
NCT04941989 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants.
NCT04958291 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate HT-4253 in Healthy Subjects
NCT06537817 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Injection of SHR-2173 in Healthy Subjects
NCT06995001 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017
NCT00791752 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of AG-348 in Healthy Volunteers
NCT02149966 ·Status: COMPLETED ·Phase: PHASE1